Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment

Gentile M;Shanafelt TD;Mauro FR;Reda G;Rossi D;Laurenti L;Del Principe MI;Cutrona G;Angeletti I;Coscia M;Herishanu Y;Chiarenza A;Molica S;Ciolli S;Goldschmidt N;Angrilli F;Giordano A;Rago A;Bairey O;Tripepi G;Chaffee KG;Sameer PA;Vigna E;Zirlik K;Shvidel L;Innocenti I;Recchia AG;Di Raimondo F;Del Poeta G;Cortelezzi A;Neri A;Ferrarini M;Gaidano G;Kay NE;Polliack A;Foà R;Morabito F

2018-01-01